| Financial Year |
March 31 2023 |
| Monetary Funds |
14,489,621.63 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
152,146,260.02 |
| Advances to Suppliers |
137,614,687.01 |
| Other Receivables |
5,137,353.55 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,174,409.63 |
| Total Current Assets |
355,017,956.03 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
107,814,501.66 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,913,333.44 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
348,558.36 |
| Deferred Income Tax Assets |
125,127,414.94 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
330,144,381.78 |
| Total Assets |
685,162,337.81 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
222,958,926.17 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,631,443.98 |
| Taxes Payable |
23,116,858.20 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
478,594,072.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
621,564,373.59 |
| Other Current Liabilities |
180,444.98 |
| Sub-Total of Current Liabilities |
1,360,363,535.57 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
11,310,611.85 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,310,611.85 |
| Total Liabilities |
1,371,674,147.42 |
| Paid-In Capital(Or Share Stock) |
384,000,000.00 |
| Capital Surplus |
81,803,411.95 |
| Surplus Reserve |
47,334,800.85 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,200,846,263.09 |
| Minority Stockholder's Interest |
1,196,240.68 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-687,708,050.29 |
| Owner's Equity（Stockholder's Equity） |
-686,511,809.61 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
685,162,337.81 |
